Amerise Biosciences Ltd. benchmarking: Perfomance to industry peers

Financial

	Amerise Biosciences	Premium Cap Mkt&Inv	Interface Financial
Operational Metrics
Financials
5 yr Average ROE	-0.9 %	8.82 %	-30.14 %
5yr average Equity Multiplier	1.27	0.88	3.34
5yr Average Asset Turnover Ratio	0.15	0.63	13.71
5yr Avg Net Profit Margin	1.22 %	-400.95 %	-4.92 %
Price to Book	0.74	0.0	0.13
P/E	84.95	0.0	0.0
5yr Avg Cash Conversion Cycle	0.0	1.07 Days	-71.12 Days
Inventory Days	0.0	14.55 Days	3.88 Days
Days Receivable	0.0	0.0	3.08 Days
Days Payable	275.57 Days	258.89 Days	20.83 Days
5yr Average Interest Coverage Ratio	-475.34	-242.5	-207.72
5yr Avg ROCE	-0.92 %	-33.11 %	-26.72 %
5yr Avg Operating Profit Margin	-0.04 %	-287.75 %	-5.11 %
5 yr average Debt to Equity	0.01	0.0	0.06
5yr CAGR Net Profit	0.0	22.87 %	-14.37 %
5yr Average Return on Assets	-1.74 %	-42.25 %	-14.19 %
Shareholdings
Promoter Holding	0.0	2.37 %	0.0
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	-41.15 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0